AdvisorShares Announces Reverse Split of ETF
- Investing.com
Upside | ||||||
|---|---|---|---|---|---|---|
| MNMD | 8.95% | aa.aa | 6.540 | +6.34% | 119,593 | |
| STIM | 8.38% | aa.aa | 4.295 | -3.05% | 155,534 | |
| CMPS | 7.34% | aa.aa | 3.99 | +5.25% | 168,541 | |
| NRXP | 7.07% | aa.aa | 2.050 | +0.50% | 297,797 | |
| ALKS | 7.03% | aa.aa | 31.46 | +4.41% | 19,975 | |
| QNTM | 6.78% | aa.aa | 12.600 | +5.00% | 66,990 | |
| ATAI | 6.74% | aa.aa | 1.475 | +6.12% | 415,762 | |
| SAGE | 6.50% | aa.aa | 6.77 | +3.13% | 83,642 | |
| CYBN | 6.25% | aa.aa | 9.60 | -1.54% | 81,383 | |
| DRUG | 5.19% | aa.aa | 45.24 | +2.40% | 13,981 |
AdvisorShares Trust - AdvisorShares Psychedelics ETF is an exchange traded fund launched and managed by AdvisorShares Investments, LLC. The fund invests in public equity markets of global region. It invests directly and through derivatives in stocks of companies operating across healthcare, pharmaceuticals, biotechnology and life sciences companies focused on plant-based psychedelic medicines as well as other companies with business activities in the psychedelics industry sectors. The fund uses derivatives such as swaps to create its portfolio. It invests in growth and value stocks of companies across diversified market capitalization. AdvisorShares Trust - AdvisorShares Psychedelics ETF was formed on September 15, 2021 and is domiciled in the United States.